Frespaciguat (MK-5475) in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009)

NCT04425733 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business reasons

Conditions

Coronavirus Disease 2019 (COVID-19)
Pneumonia
Hypoxemia

Interventions

DRUG: Frespaciguat
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC